| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/11/2011 | WO2011097181A2 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders |
| 08/11/2011 | WO2011097031A2 Monomeric forms of human aminoacyl-trna synthetases having non-canonical biological activities |
| 08/11/2011 | WO2011097029A1 Methods of inhibiting retrovirus replication and infectivity |
| 08/11/2011 | WO2011096775A2 Two-stage apparatus for artificial insemination, capable of simultaneously carrying reproductive cells of cattle and fertilization promoting materials and injecting the reproductive cells and the fertilization promoting materials into a uterus through a single procedure |
| 08/11/2011 | WO2011096756A2 Pharmaceutical composition for inhibiting abnormal proliferation of cells |
| 08/11/2011 | WO2011096558A1 Easy-disintegrating polymeric micelle composition |
| 08/11/2011 | WO2011096374A1 Novel iodobenzyl-bleomycin compound |
| 08/11/2011 | WO2011095769A1 Actagardine derivatives, and pharmaceutical use thereof |
| 08/11/2011 | WO2011095768A1 Lantibiotic salts |
| 08/11/2011 | WO2011095705A2 Novel caspase-14 activator peptides and compositions comprising said peptides |
| 08/11/2011 | WO2011095628A1 Fusion proteins comprising antigenic apob-100 protein fragments and a protein carrier, related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| 08/11/2011 | WO2011095604A1 Half-life prolongation of proteins |
| 08/11/2011 | WO2011095389A1 Use of theobromine for lowering central blood pressure |
| 08/11/2011 | WO2011095339A1 A composition for use in the therapy of lactose intolerance or conditions arising from lactase deficiency |
| 08/11/2011 | WO2011095220A1 Template - fixed peptidomimetics with cxcr7 modulating activity |
| 08/11/2011 | WO2011095174A1 Human herpes virus 6 and 7 u20 polypeptide and polynucleotides for use as a medicament or diagnosticum |
| 08/11/2011 | WO2011094806A1 Diagnostic and prognostic assay for breast cancer |
| 08/11/2011 | WO2011075393A3 Glucagon/glp-1 receptor co-agonists |
| 08/11/2011 | WO2011073629A3 Cancer diagnosis and treatment |
| 08/11/2011 | WO2011070358A3 Systemic administration of an agent that permeabilises tumour vasculature |
| 08/11/2011 | WO2011048479A3 Compositions that include anthocyanidins and methods of use |
| 08/11/2011 | WO2011043809A9 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 08/11/2011 | WO2011038014A3 Composition and method for treatment of diabetes |
| 08/11/2011 | WO2011030148A3 Improvements in or relating to exfoliation |
| 08/11/2011 | WO2011020056A3 Methods of treating cancer using galanin retargeted endpeptidases |
| 08/11/2011 | WO2011008823A9 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
| 08/11/2011 | WO2010132370A8 Soluble trem-1 family peptides and methods of use |
| 08/11/2011 | US20110197294 Compositions and methods for restoring mitochondrial electron transfer function |
| 08/11/2011 | US20110196383 Atherosclerotic Plaque Dissolution Composition |
| 08/11/2011 | US20110196128 Murine zcytor17 ligand polynucleotides |
| 08/11/2011 | US20110196021 High Affinity Nucleic Acid Ligands of Complement System Proteins |
| 08/11/2011 | US20110196019 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/11/2011 | US20110196018 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 08/11/2011 | US20110195916 Cytokine protein family |
| 08/11/2011 | US20110195915 Method of inhibiting prostate cancer cell proliferation |
| 08/11/2011 | US20110195914 Macrocyclic antiproliferation agents and methods of treatment |
| 08/11/2011 | US20110195913 Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer |
| 08/11/2011 | US20110195912 Oligomer-Protease Inhibitor Conjugates |
| 08/11/2011 | US20110195911 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof |
| 08/11/2011 | US20110195910 Use of tocotrienol composition for the prevention of cancer |
| 08/11/2011 | US20110195909 Novel x-conotoxin peptides (-ii) |
| 08/11/2011 | US20110195908 Prosaposin as a neurotrophic factor |
| 08/11/2011 | US20110195907 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 08/11/2011 | US20110195906 Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same |
| 08/11/2011 | US20110195905 Apls for treating arthritis |
| 08/11/2011 | US20110195904 Methods of treatment using exendin peptides or glp-1 peptides |
| 08/11/2011 | US20110195903 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 08/11/2011 | US20110195902 Fusion Protein Composed of Matrix Metalloproteinase-2 Inhibitor Peptide Derived From Amyloid-B Precursor Protein and Tissue Inhibitor of Metalloproteinase-2 |
| 08/11/2011 | US20110195901 Artery- and vein-specific proteins and uses therefor |
| 08/11/2011 | US20110195900 Peptidic pth receptor agonists |
| 08/11/2011 | US20110195899 Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid |
| 08/11/2011 | US20110195898 Treatment of alzheimer's disease and mild cognitive impairment using gnrh-i analogs and one or more of acetylcholinesterase inhibitors and nmda receptor antagonists |
| 08/11/2011 | US20110195897 Glycosylated glp-1 peptide |
| 08/11/2011 | US20110195896 Isoform-specific insulin analogues |
| 08/11/2011 | US20110195895 Fgf21 mutants and uses thereof |
| 08/11/2011 | US20110195894 Cd5 pharmaceutical compositions for the treatment of infectious and inflammatory processes of fungal origin |
| 08/11/2011 | US20110195893 Use of apolipoproteins to decrease inflammation |
| 08/11/2011 | US20110195892 Artifical Pulmonary Surfactant Compositions |
| 08/11/2011 | US20110195891 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 08/11/2011 | US20110195456 Methods and compositions for the production of monoclonal antibodies |
| 08/11/2011 | US20110195128 Treating or preventing gout |
| 08/11/2011 | US20110195124 Phase-transition polymeric microneedles |
| 08/11/2011 | US20110195123 Methods, compositions and systems for local delivery of drugs |
| 08/11/2011 | US20110195112 Use of plant-derived recombinant growth factors in skin care |
| 08/11/2011 | US20110195110 Urea compounds useful in the treatment of cancer |
| 08/11/2011 | US20110195103 Cosmetic or dermopharmaceutical composition containing pseudoalteromonas ferment extract |
| 08/11/2011 | US20110195102 Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions |
| 08/11/2011 | US20110195097 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 08/11/2011 | US20110195078 Tat-based immunomodulatory compositions and methods for their discovery and use |
| 08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |
| 08/11/2011 | US20110195075 Use of a pneumococcal p4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 08/11/2011 | US20110195073 Compositions and methods for stimulating an immune response |
| 08/11/2011 | US20110195072 Non-neuroendocrine cancer therapy |
| 08/11/2011 | US20110195070 Detection of granulosa-cell tumors |
| 08/11/2011 | US20110195068 Pd-1 antagonists and methods of use thereof |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | US20110195066 Quinoline inhibitors of tyrosine kinase |
| 08/11/2011 | US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor |
| 08/11/2011 | US20110195062 Mammalian Cytokines; Related Reagents and Methods |
| 08/11/2011 | US20110195061 Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha |
| 08/11/2011 | US20110195058 Cardiovascular support supplement and compositions and methods thereof |
| 08/11/2011 | US20110195049 Compositions and methods for treating multiple sclerosis |
| 08/11/2011 | US20110195048 Regulation of lymphocytes and uses therefor |
| 08/11/2011 | US20110195047 Oncostatin m as promoter of immunostimulatory activity of human epithelial cells |
| 08/11/2011 | US20110195046 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 08/11/2011 | US20110195045 Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors |
| 08/11/2011 | US20110195044 Hepatitis C Virus Inhibitors |
| 08/11/2011 | US20110195043 Dimeric Smac Mimetics |
| 08/11/2011 | US20110195039 Hair building solid agent |
| 08/11/2011 | US20110195031 Methods for the use of progestogen as a glucocorticoid sensitizer |
| 08/11/2011 | US20110195023 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 08/11/2011 | US20110195020 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses |
| 08/11/2011 | US20110195019 Nucleic acids and corresponding proteins entitled 251p5g2 useful in treatment and detection of cancer |
| 08/11/2011 | US20110192748 Administration of Dipeptidyl Peptidase Inhibitors |
| 08/11/2011 | US20110192396 Pharmaceutical composition for preventing or treating chronic obstructive pulmonary disease |
| 08/11/2011 | DE102010009582A1 Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz Means for use with lactase deficiency and lactose intolerance |
| 08/11/2011 | CA2826611A1 A composition for use in the therapy of lactose intolerance or conditions arising from lactase deficiency |
| 08/11/2011 | CA2789164A1 Lantibiotic salts |
| 08/11/2011 | CA2789120A1 Fusion proteins comprising antigenic apob-100 protein fragments and a protein carrier, related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| 08/11/2011 | CA2789030A1 Template - fixed peptidomimetics with cxcr7 modulating activity |